A MONOCLONAL-ANTIBODY TO ALPHA-4 INTEGRIN SUPPRESSES AND REVERSES ACTIVE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

被引:184
作者
KENT, SJ
KARLIK, SJ
CANNON, C
HINES, DK
YEDNOCK, TA
FRITZ, LC
HORNER, HC
机构
[1] UNIV WESTERN ONTARIO HOSP,DEPT DIAGNOST RADIOL,LONDON,ON N6A 5A5,CANADA
[2] UNIV WESTERN ONTARIO HOSP,DEPT NUCL MED,LONDON,ON N6A 5A5,CANADA
[3] UNIV WESTERN ONTARIO HOSP,DEPT PHYSIOL,LONDON,ON N6A 5A5,CANADA
[4] ATHENA NEUROSCI,S SAN FRANCISCO,CA 94080
关键词
ADHESION MOLECULES; VLA4; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TREATMENT; ALPHA-4-BETA-1; INTEGRIN;
D O I
10.1016/0165-5728(94)00165-K
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In experimental allergic encephalomyelitis (EAE), circulating leukocytes enter the central nervous system (CNS) producing inflammation, myelin damage and paralysis. Prevention of leukocyte infiltration by an antibody against alpha 4 integrin suppressed clinical and pathological features of EAE in the guinea pig. Rapid clearance of leukocytes from the CNS and reversal of clinical findings were observed when anti-alpha 4 treatment was administered during active disease. Clinical improvement was accompanied by a marked decrease in abnormal pathological findings, including demyelination. Therefore anti-alpha 4 is an effective treatment of EAE and may be similarly useful in the treatment of autoimmune diseases such as multiple sclerosis.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 47 条
[1]  
Alvord EC, 1984, EXPT ALLERGIC ENCEPH
[2]   INHIBITION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY AN ANTIBODY TO THE INTERCELLULAR-ADHESION MOLECULE ICAM-1 [J].
ARCHELOS, JJ ;
JUNG, S ;
MAURER, M ;
SCHMIED, M ;
LASSMANN, H ;
TAMATANI, T ;
MIYASAKA, M ;
TOYKA, KV ;
HARTUNG, HP .
ANNALS OF NEUROLOGY, 1993, 34 (02) :145-154
[3]   CYTOKINES IN THE CENTRAL-NERVOUS-SYSTEM OF MICE DURING CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
BAKER, D ;
ONEILL, JK ;
TURK, JL .
CELLULAR IMMUNOLOGY, 1991, 134 (02) :505-510
[4]   SURFACE EXPRESSION OF ALPHA-4 INTEGRIN BY CD4 T-CELLS IS REQUIRED FOR THEIR ENTRY INTO BRAIN PARENCHYMA [J].
BARON, JL ;
MADRI, JA ;
RUDDLE, NH ;
HASHIM, G ;
JANEWAY, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (01) :57-68
[5]  
BROSTOFF SW, 1984, J IMMUNOL, V133, P1938
[6]   ANTIADHESION MOLECULE THERAPY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS [J].
CANNELLA, B ;
CROSS, AH ;
RAINE, CS .
JOURNAL OF NEUROIMMUNOLOGY, 1993, 46 (1-2) :43-56
[7]  
CLAYBERGER C, 1987, J IMMUNOL, V138, P1510
[8]   VASCULAR CELL-ADHESION MOLECULE-1 INDUCES T-CELL ANTIGEN RECEPTOR-DEPENDENT ACTIVATION OF CD4+ LYMPHOCYTES-T [J].
DAMLE, NK ;
ARUFFO, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6403-6407
[9]   PHARMACOLOGICAL COMPARISON OF ACTIVE AND PASSIVE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE RAT [J].
DESAI, S ;
BARTON, R .
AGENTS AND ACTIONS, 1989, 27 (3-4) :351-355
[10]   IMMUNOTHERAPY OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) - DIFFERENTIAL EFFECT OF ANTI-IL-2 RECEPTOR ANTIBODY THERAPY ON ACTIVELY INDUCED AND T-LINE MEDIATED EAE OF THE LEWIS RAT [J].
ENGELHARDT, B ;
DIAMANTSTEIN, T ;
WEKERLE, H .
JOURNAL OF AUTOIMMUNITY, 1989, 2 (01) :61-73